Literature DB >> 8893440

Survival rates of patients with metastatic spinal cancer after scintigraphic detection of abnormal radioactive accumulation.

H Tatsui1, T Onomura, S Morishita, M Oketa, T Inoue.   

Abstract

STUDY
DESIGN: This retrospective study analyzes the timing of spinal metastases and the survivability of patients with cancer after the detection of spinal metastases.
OBJECTIVE: To evaluate the timing of spinal metastases in primary lesions and the survivability of patients with metastatic spinal tumors. SUMMARY OF BACKGROUND DATA: Few studies have analyzed the influence of primary lesions on survival rates of patients with metastatic spinal tumors.
METHODS: This is a review of bone scintigraphy that was performed serially in patients with pulmonary cancer, breast cancer, prostatic cancer, cervical cancer, renal cancer, and gastric cancer from 1980 to 1991. To exclude false positive cases, the spinal areas showing abnormal accumulation on bone scintigrams were further examined by other methods of diagnostic imaging. The timing of scintigraphic detection of spinal metastases and the survivability were studied in 425 patients with spinal metastases. The survivability after spinal accumulation was determined by the Kaplan-Meier survival curve.
RESULTS: The mean period, from the diagnosis of the primary lesion to the detection of abnormal accumulation in the spine, was shortest in pulmonary cancer (3.6 +/- 6.1 months), and it was longest in breast cancer (29.4 +/- 33.5 months). The 1-year survival rate was high in breast cancer (78%) and prostatic cancer (83%), and it was low in pulmonary cancer (22%) and gastric cancer (0%), respectively. The 6-month survival rate of gastric cancer was 15%.
CONCLUSIONS: When managing metastatic spinal tumors, it is essential to select therapeutic methods based on adequate consideration of the features of primary lesions and the expected prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8893440     DOI: 10.1097/00007632-199609150-00017

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  25 in total

1.  Clinical profile of long-term survivors of breast or thyroid cancer with metastatic spinal tumours.

Authors:  Y Kasai; E Kawakita; A Uchida
Journal:  Int Orthop       Date:  2006-04-26       Impact factor: 3.075

Review 2.  Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group.

Authors:  David Choi; A Crockard; C Bunger; J Harms; N Kawahara; C Mazel; R Melcher; K Tomita
Journal:  Eur Spine J       Date:  2009-12-29       Impact factor: 3.134

3.  [Diagnostics and therapy of spinal metastases].

Authors:  H Pilge; B M Holzapfel; P M Prodinger; M Hadjamu; H Gollwitzer; H Rechl
Journal:  Orthopade       Date:  2011-02       Impact factor: 1.087

4.  Incidence and outcome of bone metastatic disease at University Malaya Medical Centre.

Authors:  Vivek Ajit Singh; Amber Haseeb; Alla Allden H Ali Alkubaisi
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

Review 5.  Metastasis to nervous system: spinal epidural and intramedullary metastases.

Authors:  Melike Mut; David Schiff; Mark E Shaffrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

6.  Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.

Authors:  Jiangtao Shen; Xinru Du; Lingxiu Zhao; Hui Luo; Ziyu Xu
Journal:  Oncol Lett       Date:  2018-04-24       Impact factor: 2.967

7.  Finding cancer in primary care outpatients with low back pain: a comparison of diagnostic strategies.

Authors:  J D Joines; R A McNutt; T S Carey; R A Deyo; R Rouhani
Journal:  J Gen Intern Med       Date:  2001-01       Impact factor: 5.128

8.  Rapid magnetic resonance imaging for diagnosing cancer-related low back pain.

Authors:  William Hollingworth; Darryl T Gray; Brook I Martin; Sean D Sullivan; Richard A Deyo; Jeffrey G Jarvik
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

9.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

10.  Percutaneous kyphoplasty for the treatment of spinal metastases.

Authors:  Feng Chen; Yong-Hui Xia; Wen-Zhen Cao; Wei Shan; Yang Gao; B O Feng; Difei Wang
Journal:  Oncol Lett       Date:  2016-01-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.